Irving Wainer
0000-0003-1643-5845
Spirify Pharma
2 papers found
Refreshing results…
Deprogramming metabolism in pancreatic cancer with a bi-functional GPR55 inhibitor and biased β2 adrenergic agonist
GPR55 receptor antagonist decreases glycolytic activity in PANC‐1 pancreatic cancer cell line and tumor xenografts
Missing publications? Search for publications with a matching author name.